CAC Score RCA/PDA

A standard coronary calcium scan gives you one big number, but the arteries on the right side of your heart can tell their own story. Calcium showing up in the right coronary artery (RCA) and its main branch, the posterior descending artery (PDA), means atherosclerosis has set up shop in the vessel system that feeds the back wall of your heart, and that location matters for how risk plays out.

Vessel-by-vessel calcium scoring is becoming part of how preventive cardiologists read a CT scan. The number of vessels involved, and whether the calcium sits in proximal segments, can sharpen risk prediction beyond the total score alone. This is your read on the right coronary territory.

What This Score Actually Measures

Coronary artery calcium (CAC) refers to calcium deposits inside atherosclerotic plaque in the wall of a coronary artery. A non-contrast cardiac CT picks up these deposits because calcium blocks X-rays sharply. The total Agatston score adds up calcium across all the heart's main arteries. The RCA/PDA score isolates the calcium found in the right coronary artery and the posterior descending artery that usually arises from it.

Calcium is not the active disease itself. It is the fingerprint atherosclerosis leaves behind as plaques mature, and it acts as a structural record of how much arterial damage has accumulated over years. A positive RCA/PDA score means real plaque exists there. A zero in this territory means no calcified plaque was detected on that scan, though it does not fully rule out softer, non-calcified plaque, especially in younger people.

Why Vessel Location Matters

Total CAC is a strong predictor of future cardiovascular events on its own. But research from the Coronary Artery Calcium Consortium, covering 54,678 people, found that adding the number of calcified vessels to the Agatston score (the CAC-DRS system) sharpens prediction of coronary heart disease, cardiovascular mortality, and all-cause death compared with the score alone. More vessels involved means higher risk, even at the same total score.

Where the calcium sits inside a vessel also matters. In the EISNER study of 2,047 asymptomatic adults with mild CAC scores of 1 to 99, calcium in proximal segments (including the proximal RCA) independently raised the risk of myocardial infarction, late revascularization, or cardiac death about threefold over roughly 14 years, even after adjusting for total CAC and traditional risk factors. The Framingham Heart Study analysis of 1,268 community-dwelling adults reached a similar conclusion: calcium in the proximal dominant coronary artery, which is usually the RCA in right-dominant anatomy, independently predicted major coronary heart disease events.

Heart Attack and Death Risk

Across cohorts, climbing CAC scores track tightly with climbing event risk. A meta-analysis of about 34,000 symptomatic adults showed that higher CAC strongly raises the risk of major adverse cardiac events. Among 23,637 adults followed in the Walter Reed Cohort Study, CAC scoring improved long-term prediction of heart attack, stroke, and death well beyond traditional risk equations. RCA/PDA involvement contributes to this picture as part of overall plaque burden and distribution.

At the high end, calcium does not plateau. In 66,636 asymptomatic adults from the CAC Consortium, those with total CAC of 1,000 or higher carried noticeably greater cardiovascular and all-cause mortality than people with CAC between 400 and 999. The takeaway is that more calcium, including more calcium in the right coronary system, keeps signaling more risk as the number climbs.

The Counterintuitive Side: Density and Statins

Two findings can feel like they contradict the basic story. First, in 3,398 adults from the Multi-Ethnic Study of Atherosclerosis, higher calcium density at a given calcium volume was associated with lower future event risk, not higher. Second, statins, which clearly reduce heart attacks, tend to raise CAC scores rather than lower them. In a serial CT angiography study, statin users showed increased calcified plaque but reduced non-calcified plaque, consistent with calcium acting as a marker of plaque stabilization rather than disease worsening.

These findings make sense once you stop reading CAC as a simple smoke detector. It reflects two things at once: how much plaque is there, and how mature or stable that plaque has become. More plaque is bad. More densely calcified plaque, for a given amount, may indicate a more stable, less rupture-prone lesion. The framework that resolves the apparent paradox: total burden drives risk upward, while density within that burden can signal a quieter, more healed phenotype.

Tracking Your Trend

A single CAC scan, including the RCA/PDA component, captures one moment in a years-long process. Calcium does not develop overnight, and it rarely disappears. What matters most is the trajectory: is calcified plaque accumulating, holding steady, or progressing rapidly despite treatment? Studies of CAC progression typically rescan after about three years, with annual increases of 100 Agatston units or more flagged as meaningful progression.

If your initial RCA/PDA score is zero and your overall total score is also zero, a rescan in three to five years is reasonable, with the caveat that younger adults can still develop non-calcified plaque in the meantime. If calcium is already present, rescanning every three to five years tracks progression and shows whether interventions are slowing the curve. Get a baseline now, address the modifiable drivers, then use the next scan as a scoreboard.

What to Do With an Out-of-Pattern Result

If calcium shows up in the RCA/PDA, especially in proximal segments, treat that as a signal to intensify, not panic. The next steps are not another scan tomorrow. They are a thorough workup of why plaque is forming and how to slow it. That usually means a full lipid panel including ApoB and lipoprotein(a), markers of insulin resistance and inflammation like fasting insulin and high-sensitivity C-reactive protein (hs-CRP), blood pressure assessment, and a frank look at family history.

Combinations matter more than any single number. RCA/PDA calcium plus elevated ApoB plus high lipoprotein(a) plus a family history of premature heart disease describes a far more aggressive risk picture than calcium alone. A preventive cardiologist or lipidologist is the right partner here. Coronary CT angiography (CCTA) is the natural next imaging step if there is concern about lumen-narrowing plaque, since it can show stenosis directly and identify soft, non-calcified plaque that calcium scoring misses.

When Results Can Be Misleading

A few situations can muddy interpretation of an RCA/PDA score:

• Younger adults with a score of zero: in symptomatic patients under about 55, a zero does not reliably exclude coronary plaque the way it does in older adults; sensitivity for detecting any plaque rises from 53 to 73 percent in people under 55 to 86 to 93 percent in those 55 and older.
• Coronary stents in the RCA: existing stents create artifact and can be mistakenly counted as native calcium unless software or a reader specifically excludes them.
• Left-dominant circulation: in roughly 10 to 15 percent of people, the PDA branches off the left circumflex instead of the RCA, so a low RCA/PDA score in a left-dominant heart does not mean the back wall of the heart is calcium-free.
• Statin therapy: if you have been on a statin, expect calcium scores to rise over time even as event risk falls, so progression on therapy needs to be interpreted as plaque maturation, not necessarily disease acceleration.

How This Fits Into a Broader Picture

Vessel-specific CAC, including RCA/PDA, adds resolution to the standard total Agatston score, but it does not replace it. The total score, the number of vessels involved, the location of calcium within each vessel, and the density of that calcium all carry signal. Combined with blood-based markers of atherogenic particle number (ApoB), inherited lipid risk (lipoprotein(a)), and metabolic health, your right coronary calcium number becomes part of a much sharper individual risk profile than any single test could provide.